Study of Peripheral Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab.
Phase of Trial: Phase IV
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Acronyms EUSpA
- Sponsors Merck Sharp & Dohme
- 02 Nov 2012 Planned number of patients changed from 100 to 120 as reported by European Clinical Trials Database.
- 10 Mar 2010 Actual patient number (7) added as reported by ClinicalTrials.gov.
- 07 Dec 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.